Nitric oxide synthase inhibitor attenuates inflammatory lesions in the skin of zinc-deficient rats

Nutrition

Volumn 16, Issue 1, 2000, Pages 34-41

  Cui, Li ^a   Takagi, Yoji ^a   Sando, Kinya ^a   Wasa, Masafumi ^a   Okada, Akira ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; Nitric oxide synthase inhibitor; Rats; Skin lesions; Zinc deficiency

Indexed keywords

EVANS BLUE; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; ZINC;

ALOPECIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BALANITIS; CELL INFILTRATION; CONTROLLED STUDY; DERMATITIS; DERMIS; DIET SUPPLEMENTATION; EPIDERMIS; GENE EXPRESSION; MALE; MICROVASCULATURE; NONHUMAN; PARAKERATOSIS; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BLOOD FLOW; SKIN DEFECT; SKIN INFLAMMATION; STOMATITIS; SUBCUTANEOUS TISSUE; ZINC DEFICIENCY;

ANIMALS; APOPTOSIS; CAPILLARY PERMEABILITY; DERMATITIS; DRINKING; ENZYME INHIBITORS; IN SITU NICK-END LABELING; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; ZINC;

ANIMALIA;

EID: 0033964466     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(99)00185-9     Document Type: Article

References (32)

1. Cohen I.K., Schechter P.J., Henkin R.I. Hypogeusia, anorexia and altered zinc metabolism following thermal burn. JAMA. 223:1973;914.
2. Molokhia M.M., Portnoy B. Neutron activation analysis of trace elements in skin. III. Zinc in normal skin. Br J Dermatol. 81:1969;759.
3. Okada A., Takagi Y., Itakura T., et al. Skin lesions during intravenous hyperalimentation zinc deficiency. Surgery. 80:1976;629.
4. Daniel O., Haddad F., Prout G., Whitmore W.F. Some observation on the distribution of radioactive zinc in prostatic and other human tissues. Br J Urol. 28:1956;271.
5. Vallance P., Moncada S. Nitric oxide from mediator to medicines. J R Coll Phys Lond. 28:1994;209.
6. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051.
7. Qureshi A.A., Lerner L.H., Lerner E.A. From bedside to the bench and back. Nitric oxide and the cutis. Arch Dermatol. 132:1996;889.
8. Cui L., Takagi Y., Wasa M., et al. Induction of nitric oxide synthase in rat intestine by interleukin-1α may explain diarrhea associated with zinc-deficiency. J Nutr. 127:1997;1729.
9. Lange S., Delbro D.S., Jennische E. Evans blue permeation of intestinal mucosa in rat. Scand J Gastroenterol. 29:1994;38.
10. Lippe I.T., Stabentheiner A., Holzer P. Participation of nitric oxide in the mustard oil-induced neurogenic inflammation of the rat paw skin. Eur J Pharmacol. 232:1993;113.
11. Steller H. Mechanisms and genes of cellular suicide. Science. 267:1995;1445.
12. Fraker P, Telford W. Regulation of apoptosis events by zinc. In: Berdanier C. Nutrition and gene expression. Boca Raton: CRC Press, 1996:189.
13. Rogers J.M., Taubeneck M.W., Daston G.P., et al. Zinc deficiency causes apoptosis but not cell cycle alterations in organogenesis-stage rat embryos effect of varying duration of deficiency. Teratology. 52:1995;149.
14. Sunderman F.W. Jr. The influence of zinc on apoptosis. Ann Clin Lab Sci. 25:1995;134.
15. Cui L., Takagi Y., Wasa M., et al. Nitric oxide synthase inhibitor attenuates intestinal damage induced by zinc-deficiency in rats. J Nutr. 129:1999;792.
16. Elmes M.E., Jones J.G. Ultrastructural studies on paneth cell apoptosis in zinc deficient rats. Cell Tissue Res. 208:1980;57.
17. Fukuo K., Nakahashi T., Nomura S., et al. Possible participation of Fas-mediated apoptosis in the mechanism of atherosclerosis. Gerontology. 43:1997;35.
18. Nakazawa M., Uehara T., Nomura Y. Koningic acid (a potent glyceraldehyde-3-phosphate dehydrogenase inhibitor)-induced fragmentation and condensation of DNA in NG108-15 cells. J Neurochem. 68:1997;2493.
19. Takagi Y., Okada A., Itakura T., Kawashima Y. Clinical studies on zinc metabolism during total parenteral nutrition as related to zinc deficiency. JPEN. 10:1986;195.
20. Cui L., Takagi Y., Nezu R., et al. Prolonged zinc-deficient diet alters alkaline phosphatase and disaccharidase activities and induces morphological changes in the intestine of rats. J Trace Elem Exp Med. 8:1996;249.
21. Buerk C.A., Chandy M.G., Peason E., MacAuly A., Soroff H.S. Zinc deficiency effect on healing and metabolism in man. Surg Forum. 24:1973;101.
22. Mori H., Matsumoto Y., Tamada Y., Ohashi M. Apoptotic cell death in formation of vesicular skin lesions in patients with acquired zinc deficiency. J Cutan Pathol. 23:1996;359.
23. Radomski M.W., Palmer R.M., Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 2:1987;1057.
24. Freedman J.E., Loscalzo J., Barnard M.R., et al. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest. 100:1997;350.
25. Chander C.L., Moore A.R., Desa F.M., Howat D.W., Willoughby D.A. Anti-inflammatory effects of endothelin-1. J Cardiovasc Pharmacol. 5:1989;S218.
26. Mulligan M.S., Hevel J.M., Marletta M.A., Ward P.A. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl Acad Sci USA. 88:1991;6338.
27. Ialenti A., Moncada S., Rosa M.D.I. Modulation of adjuvant arthritis by endogenous nitric oxide. Br J Pharmacol. 110:1993;701.
28. Moore P.K., al-Swayeh O.A., Chong N.W., Evans R.A., Gibson A. L-NG-Nitro arginine (L-NOARG), a novel, L-arginine reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol. 99:1990;408.
29. Ralevic V., Khalil Z., Helme R.D., Dusting G.J. Role of nitric oxide in the actions of substance P and other mediators of inflammation in rat skin microvasculature. Eur J Pharmacol. 284:1995;231.
30. Vane J.R., Mitchell J.A., Appleton I., et al. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Pharmacology. 91:1994;2046.
31. Cho H.J., Xie Q.W., Calaycay J., et al. Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med. 176:1992;599.
32. Iadecola C., Zhang F., Xu X. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am J Physiol. 268:1995;R286.